Our mission is to make the discoveries that defeat cancer.
The ICR Strategic Plan 2011-16 outlines our direction for the next five years, based on our three strategic goals:
- Research and impact
To be a world leader in fundamental research into cancer and the translation of research discoveries into improved outcomes for cancer patients.
- Education and training
To educate and train the next generation of cancer researchers and clinicians. Find out more about our Learning, Teaching and Assessment strategy here.
- Environment and infrastructure
To deliver a world class and sustainable organisation to support cancer research and education for patient benefit.
The ICR Scientific Strategy sets out our research direction, which is based on three interlinked themes:
- genetics and epidemiology
- therapeutic development
- molecular pathology
These areas of research are essential for the development of personalised cancer medicine.
It also describes how our objectives will be delivered by:
- developing and exploiting the ICR and The Royal Marsden’s unique relationship to enhance cancer research
- ensuring the ICR has a balanced portfolio of basic and applied research
- developing treatment regimes to the genetic makeup of the patient and tumour
- attracting, developing and retaining the best staff across the whole spectrum of the ICR’s activities
The strategy aims to:
- develop key research areas while enhancing partnership affiliations
- strengthen interactions within the clinical and translational settings